After a nice three-week rally, the stock market has stalled for about the last week. The S&P 500 has been stuck within 10 points of 2000, a psychologically important level.
Most of the biotech industry has been doing the same. The iShares NASDAQ Biotechnology Index ETF IBB hit a new all-time high earlier this week, yet still sits near the same $275 mark it's been at for the last week.
There have been a few biotech stocks, however, that made significant moves this week.
The company: Arrowhead Research Corp
Ticker Symbol: ARWR
Sector: Healthcare
Industry: Biotechnology
Arrowhead Research develops targeted RNAi therapeutics in the United States.
The company’s platform technologies include Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown and induces endosomal escape.
Take a look at the one-year chart of Arrowhead, with added notations:
Arrowhead hit a rough patch back in March and April, finally bottoming around $9 towards the beginning on May.
Arrowhead has since formed a good representation of a double bottom price pattern, with the second bottom occurring in August.
Arrowhead on Wednesday broke through the $15.50-16.00 resistance zone that had been created by the double bottom pattern, thus confirming the pattern.
The stock closed at $16.27.
Always remember to use protective stops to be around for the next trade. Capital preservation is always key.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
